HOME › DRUGS › RIBOCICLIB SUCCINATE
ACTIVE SUBSTANCE / INN

RIBOCICLIB SUCCINATE

Brand name(s): LETROZOLE;VRIBOCICLIB SUCCINATE, KISQALI FEMARA CO-PACK (COPACKAGED), KISQALI
FDA LISTED
PRESCRIPTION
NONE (TENTATIVE APPROVAL)
ANDA215975
NDA209935
ACTIVE SUBSTANCE
Ribociclib Succinate
REGULATORS
FDA
SPONSORS / MAH
NOVARTIS, MSN LABS PVT LTD
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
KISQALI FEMARA CO-PACK (COPACKAGED)NDA209935NOVARTISPrescription
LETROZOLE;VRIBOCICLIB SUCCINATEANDA215975MSN LABS PVT LTDNone (Tentative Approval)
KISQALINDA209092NOVARTISPrescription

FULL INTELLIGENCE ON RIBOCICLIB SUCCINATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →